551 related articles for article (PubMed ID: 21502933)
1. A new testosterone gel (fortesta) for hypogonadism.
Med Lett Drugs Ther; 2011 Apr; 53(1362):29-30. PubMed ID: 21502933
[TBL] [Abstract][Full Text] [Related]
2. Testosterone undecanoate in the treatment of male hypogonadism.
Edelstein D; Basaria S
Expert Opin Pharmacother; 2010 Aug; 11(12):2095-106. PubMed ID: 20642374
[TBL] [Abstract][Full Text] [Related]
3. The long-term efficacy and safety of a testosterone mucoadhesive buccal tablet in testosterone-deficient men.
Dinsmore WW; Wyllie MG
BJU Int; 2012 Jul; 110(2):162-9. PubMed ID: 22288877
[TBL] [Abstract][Full Text] [Related]
4. Testosterone topical solution (Axiron) for hypogonadism.
Med Lett Drugs Ther; 2011 Jul; 53(1368):54-5. PubMed ID: 21738108
[TBL] [Abstract][Full Text] [Related]
5. Testosterone replacement therapy for male hypogonadism: part III. Pharmacologic and clinical profiles, monitoring, safety issues, and potential future agents.
Seftel A
Int J Impot Res; 2007; 19(1):2-24. PubMed ID: 16193074
[TBL] [Abstract][Full Text] [Related]
6. Testosterone replacement in elderly men.
Baum NH; Crespi CA
Geriatrics; 2007 Sep; 62(9):15-8. PubMed ID: 17824721
[TBL] [Abstract][Full Text] [Related]
7. Testosterone metabolism and replacement therapy in patients with end-stage renal disease.
Johansen KL
Semin Dial; 2004; 17(3):202-8. PubMed ID: 15144546
[TBL] [Abstract][Full Text] [Related]
8. Transdermal delivery of testosterone.
Hadgraft J; Lane ME
Eur J Pharm Biopharm; 2015 May; 92():42-8. PubMed ID: 25709060
[TBL] [Abstract][Full Text] [Related]
9. A new 2% testosterone gel formulation: a comparison with currently available topical preparations.
Arver S; Stief C; de la Rosette J; Jones TH; Neijber A; Carrara D
Andrology; 2018 May; 6(3):396-407. PubMed ID: 29600542
[TBL] [Abstract][Full Text] [Related]
10. Review of Testim gel.
McNicholas T; Ong T
Expert Opin Pharmacother; 2006 Mar; 7(4):477-84. PubMed ID: 16503819
[TBL] [Abstract][Full Text] [Related]
11. Testim 1% testosterone gel for the treatment of male hypogonadism.
Bouloux P
Clin Ther; 2005 Mar; 27(3):286-98. PubMed ID: 15878382
[TBL] [Abstract][Full Text] [Related]
12. Three-year follow-up of androgen treatment in hypogonadal men: preliminary report with testosterone gel.
Swerdloff RS; Wang C
Aging Male; 2003 Sep; 6(3):207-11. PubMed ID: 14628501
[TBL] [Abstract][Full Text] [Related]
13. Testosterone administration in older men.
Matsumoto AM
Endocrinol Metab Clin North Am; 2013 Jun; 42(2):271-86. PubMed ID: 23702401
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of testosterone replacement gel for treating hypogonadism in men: Phase III open-label studies.
Belkoff L; Brock G; Carrara D; Neijber A; Ando M; Mitchel J
Andrologia; 2018 Feb; 50(1):. PubMed ID: 28295450
[TBL] [Abstract][Full Text] [Related]
15. Jatenzo - an oral testosterone for hypogonadism.
Med Lett Drugs Ther; 2021 Jun; 63(1627):103-104. PubMed ID: 34181633
[No Abstract] [Full Text] [Related]
16. Efficacy of changing testosterone gel preparations (Androgel or Testim) among suboptimally responsive hypogonadal men.
Grober ED; Khera M; Soni SD; Espinoza MG; Lipshultz LI
Int J Impot Res; 2008; 20(2):213-7. PubMed ID: 17898800
[TBL] [Abstract][Full Text] [Related]
17. Current topics in testosterone replacement of hypogonadal men.
Nieschlag E
Best Pract Res Clin Endocrinol Metab; 2015 Jan; 29(1):77-90. PubMed ID: 25617174
[TBL] [Abstract][Full Text] [Related]
18. FPIN's clinical inquiries. Testosterone therapy and risk recurrence after treatment of prostate cancer.
Meza J; Weaver K; Martin S
Am Fam Physician; 2013 Oct; 88(8):Online. PubMed ID: 24364582
[No Abstract] [Full Text] [Related]
19. Emerging medication for the treatment of male hypogonadism.
Aydogdu A; Swerdloff RS
Expert Opin Emerg Drugs; 2016 Sep; 21(3):255-66. PubMed ID: 27552127
[TBL] [Abstract][Full Text] [Related]
20. ISA, ISSAM and EAU recommendations for the investigation, treatment and monitoring of late-onset hypogonadism in males: scientific background and rationale.
Lunenfeld B; Saad F; Hoesl CE
Aging Male; 2005 Jun; 8(2):59-74. PubMed ID: 16096160
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]